ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

ARVN Arvinas Inc

32,37
0,77 (2,44%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Arvinas Inc ARVN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,77 2,44% 32,37 18:44:30
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
31,73 31,04 32,72 32,37 31,60
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202417:30GLOBEArvinas Appoints Randy Teel, Ph.D., as Chief Business..
11/04/202408:00GLOBEArvinas Enters into a Transaction with Novartis, including a..
18/03/202417:40GLOBEArvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief..
04/03/202409:00GLOBEArvinas to Participate in Upcoming Investor Conferences
27/02/202409:00GLOBEArvinas Reports Fourth Quarter and Full Year 2023 Financial..
20/02/202418:05GLOBEArvinas Announces Chief Financial Officer Transition
20/02/202409:00GLOBEArvinas Announces First-in-Human Dosing of ARV-102, an..
14/02/202410:00GLOBECarrick Therapeutics Announces First Patient Dosed in Phase..
06/02/202408:45GLOBEArvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA..
01/02/202418:30GLOBEArvinas to Present at 6th Annual Guggenheim Biotechnology..
16/01/202419:01GLOBEArvinas Appoints Jared Freedberg as General Counsel
06/12/202300:52GLOBEArvinas to Host Conference Call and Webcast to Discuss..
05/12/202315:33GLOBEArvinas and Pfizer Announce Interim Data from Phase 1b Trial..
28/11/202319:05GLOBEArvinas and Pfizer Announce Updated Vepdegestrant (ARV-471)..
27/11/202309:00GLOBEArvinas Announces Oversubscribed $350 Million Private..
07/11/202309:00GLOBEArvinas Reports Third Quarter 2023 Financial Results and..
02/11/202308:00GLOBEArvinas to Participate in Upcoming Investor Conferences
22/10/202308:00GLOBEPotential of Arvinas’ PROTAC® AR Degraders Reinforced by..
18/10/202308:00GLOBEArvinas Gives Back to Local Greater New Haven Community in..
15/10/202319:07GLOBEArvinas Announces Upcoming Bavdegalutamide Poster..
15/10/202319:05GLOBEArvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471)..
01/09/202308:00GLOBEArvinas to Participate in Upcoming Investor Conferences
08/08/202308:00GLOBEArvinas Reports Second Quarter 2023 Financial Results and..
31/07/202317:30GLOBEArvinas and Pfizer Awarded Innovation Passport Designation..
06/07/202310:00GLOBECarrick Therapeutics Announces Clinical Trial Collaboration..
15/06/202317:30GLOBEArvinas Announces Changes to its Board of Directors
08/06/202308:00GLOBEArvinas Announces Interim Data from the ARV-766 Phase 1/2..
05/06/202308:00GLOBEArvinas to Participate in Upcoming Investor Conferences
08/05/202308:00GLOBEArvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471)..
05/05/202308:00GLOBEArvinas Reports First Quarter 2023 Financial Results and..
03/05/202308:00GLOBEArvinas to Present at the Bank of America Securities 2023..
02/05/202314:00PRNUSArvinas and Quantum Leap Healthcare Announce Clinical Study..

Seu Histórico Recente

Delayed Upgrade Clock